We have developed a cell-based 96-well microtiter plate, high throughput assay for measuring both type I and type II interferon (IFN) activity on human cells. This assay makes use of a previously described IFN-specific reporter stably expressed in human HT 1080 cells. The induction of the reporter by IFN is determined by measuring the IFN-dependent expression of CD2 on the cell surface. The cytokine-induced expression of CD2 occurs within 48 h and is measured using a time-resolved fluorometric immunoassay. The limit of detection for type I IFN is >0.4 IU/ml. Interassay and intraassay coefficients of variation were 1.1% and 1.3% for the medium control (31 IU IFNβ1b/ml), respectively. The limit of detection for type II IFN is >8 IU/ml, and the assay coefficients of variation are similar to those determined for type I IFNs. The level of sensitivity for this assay is comparable to other assays commonly used to measure IFN activity on cells. The current assay has an advantage over antiviral and antiproliferative assays, in that there is no requirement for the use of pathogenic virus or for determining viable cell numbers. The current assay is ideally suited for increasing sample screening and high-capacity automation, making it an excellent tool for drug discovery.
References
1.
Pestka, S., Langer, J.A., Zoon, K., Samuel, C. (1987). Interferons and their actions. Ann. Rev. Biochem.56:727.
2.
Uzé, G., Lutfalla, G., Mogensen, K. (1996). Alpha and beta interferons and their receptor and their friends and relations. J. Interferon Cytokine Res.15:31.
3.
IFNβ Multiple Sclerosis Study Group. (1993). Interferon beta-bl is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology43:655.
4.
Davis, G., Balart, L., Schiff, E., Lindsay, K. and Bodenheimer, C. (1989). Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. N. Engl. Med.321:1501
5.
Dorr, R.T. (1993). Interferon alpha in malignant and viral diseases: A review. Drugs45:177.
6.
Pellegrini, S., Schindler, C. (1994). Early events in signaling by interferons. Trends Biochem. Sci.18:338.
7.
Reid, L.E., Brasnett, A.H., Gilbert, C.S., Porter, A.C., Gewert, D.R., Stark, G.R., Kerr, I.M. (1989). A single DNA response element can confer inducibility by both alpha- and gamma-interferons. Proc. Natl. Acad. Sci. U.S.A.86:840.
8.
Forti, R., Schuffman, S., Davies, H., Michell, W. (1986). Objective antiviral assay of the interferons by computer assisted data collection and analysis. Meth. Enzymol.119:533.
9.
Watling, D., Guschin, D., Muller, M., Sivennoinen, O., Witthuhn, B.A., Quelle, F., Rogers, N.C., Schindler, C., Stark, G.R., Ihle, J., Kerr, I.M. (1993). Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway. Nature366:166.
10.
Russell-Harde, D., Knauf, M., Croze, E. (1995). The use of Zwittergent 3-14 in the purification of recombinant human interferon β ser17 (Betaseron). J. Interferon Cytokine Res.15:31.
11.
Hemmila, I. (1988). Lanthanides as probes for time resolved fluorometric immunoassays. Scand. J. Clin. Lab Invest.48:389.
12.
Soini, E., Lövgren, T. (1987). Time resolved fluorescence of lanthanide probes and applications in biotechnology. CRC Crit. Rev. Anal. Chem.18:505.
13.
Croze, E., Russell-Harde, D., Wagner, T.C., Pu, H., Driller, J., Twu, J., Perez, H.D. (1996). Differential ligand binding properties of soluble IFNAR2 and IFNAR1. Eur. Cytokine Netw.7:612.
14.
Croze, E., Russell-Harde, D., Wagner, T.C., Pu, H., Pfeffer, L., Perez, H.D. (1996). The human type I interferon receptor. Identification of the interferon beta-specific receptor associated phosphoprotein. J. Biol. Chem.271:33165.
15.
Novick, D., Cohen, B., Rubinstein, M. (1994). The human interferon alpha/beta receptor: Characterization and molecular cloning. Cell77:391.
16.
Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P., Colamonici, O. (1995). Cloning and expression of a long form of the beta subunit of the interferon alpha/beta receptor that is required for signaling. J. Biol. Chem.270:21606.
17.
Lutfalla, G., Holland, S.J., Cinato, E., Monneron, D., Reboul, J., Rogers, N.C., Smith, J.M., Stark, G., Gardiner, K., Mogensen, K.E., Kerr, I.M., Uzé, G. (1996). Mutant USA cells are complemented by an interferon α/β receptor subunit generated by alternative processing of a new member of a cytokine receptor gene. EMBO J.14:5100.
18.
Aebersold, P., Sample, S. (1986). A simplified antigrowth assay based on color change of the medium. Meth. Enzymol.119:579.
19.
Evinger, M., Pestka, S. (1981). Assay of growth inhibition in lymphoblastoid cell cultures. Meth. Enzymol.79:362.
